Abstract
6-Deoxy-6-[18F]fluoro-L-threo-2,3-hexodiulosonic acid γ-lactone(6-[18F]fluoro-dehydroascorbic acid, 18F-FDHA)was synthesized by oxidation of 6-deoxy-6-[18F]fluoro-L-ascorbic acid(18F-DFA)with Br2, a route that is analogous to the original synthesis of FDHA, in order to develop a radiotracer for nuclear medical imaging. Tissue biodistribution of 18F-FDHA in fibrosarcoma-bearing mice showed a low accumulation of radioactivity in the brain, with both substantial in vivo defluorination and low tumoral uptake levels. Several organs of mice unfed for 24h showed a more significant increase in radioactivity postinjection of 18F-FDHA than did fed mice. Co-injection with 2-deoxyglucose of 18F-FDHA did not significantly alter brain and tumor uptake, as confirmed by tissue-to-blood ratios, and as compared to control experiments. Thus, 18F-FDHA does not exhibit desirable properties as a brain-targeting imaging agent for ascorbic acid bioactivity.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
